Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide-based Quadruple Regimen for H. pylori
NCT02621359Phase 3Unknown
- Sponsor
- Tanta University
- Start
- Jan 2015
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nitazoxanide in Helicobacter pylori infection, sponsored by Tanta University. Status: unknown.
02
Drugs
nitazoxanide
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02621359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02621359.